Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of the Breast Tumor Microenvironment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
AVID100 in Advanced Epithelial Carcinomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ribociclib and Bicalutamide in AR+ TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2